证券日报网讯 12月29日，同有科技在互动平台回答投资者提问时表示，公司持续关注市场动态，并结 合行业上游采购成本及下游销售市场需求变化等因素适时调整产品价格。 （文章来源：证券日报） ...

格隆汇12月29日丨同有科技(300302.SZ)在互动平台表示，公司自主可控存储系统产品在卫星大数据场 景实现规模化应用，可为卫星大数据的实时码流数据接收、数据解析、数据处理和存储全链条提供高效 解决方案。 ...

（文章来源：证券日报） 证券日报网讯 12月19日，同有科技发布公告称，公司第五届董事会第十五次会议审议通过《关于公司 向银行申请授信额度的议案》。 ...

Group 1 - Sichuan Chengyu's wholly-owned subsidiary plans to acquire 85% equity of Hubei Jingyi Company for 2.409 billion yuan, enhancing the company's control over highway projects [1] - Huadian Technology signed contracts worth approximately 815 million yuan with Huadian Technology Group for a wind power hydrogen production project [2] - Dongfang Cable and its subsidiary won projects totaling approximately 3.125 billion yuan, accounting for 34.37% of the company's audited revenue for 2024 [3] Group 2 - Heng Rui Medicine received approval for clinical trials of SHR-2906 injection, a self-developed biopharmaceutical aimed at weight control and metabolic regulation [4] - Qingdao Port plans to invest approximately 15.7 billion yuan in two terminal projects [5] - Jingu Co. received a notification to supply low-carbon wheels for two export models to a major domestic car manufacturer, with production expected in 2026 [6] Group 3 - ST Xingguang won a procurement project worth approximately 22.955 million yuan, accounting for 11.96% of the company's revenue for 2024 [7] - Xinbo Co. plans to jointly invest in an alloy materials research institute with partners, focusing on high-performance materials for various industries [8] - Tianqi Lithium's third-phase lithium concentrate expansion project has been completed and is undergoing trial production, with a total capacity of 2.14 million tons per year [9] Group 4 - Changfei Fiber reported that new fiber optic products related to data centers represent a small proportion of total demand [10] - Dongfang Bio's subsidiaries obtained multiple medical device registration certificates, including various testing kits [11] - Xiugang Co. plans to use up to 500 million yuan of idle fundraising for cash management in safe, liquid investment products [12] Group 5 - Jifeng Co. received a project designation for passenger car seat assemblies from a European luxury brand, with a total lifecycle value of approximately 9.8 billion yuan [13] - CanSino initiated Phase I clinical trials for a combined vaccine, completing the first subject enrollment [14] - Dayu Water-saving's subsidiary pre-won a drainage project worth 140 million yuan and another project worth 1 billion yuan [15] Group 6 - Yutong Pharmaceutical's subsidiary received clinical trial approval for YKYY032 injection for treating hyperlipoproteinemia [17] - Diweier announced the departure of a core technical personnel, impacting its technical leadership [18] - Weilang Co.'s controlling shareholder received regulatory measures from the Shandong Securities Regulatory Bureau for failing to fulfill a commitment [19] Group 7 - Xiehe Electronics invested 5 million yuan in a private equity fund focusing on hard technology sectors [20] - Phoenix Optical received a government subsidy of 4.7053 million yuan, representing 35% of its projected net profit for 2024 [21] - China State Construction reported a 0.9% year-on-year increase in new contracts signed in the first 11 months of 2025, totaling 4.0408 trillion yuan [22] Group 8 - Nanguang Energy's pumped storage power station units 1 and 2 have entered trial operation, with units 3 and 4 expected to follow by year-end [23] - Jindalai plans to invest 280 million yuan to acquire a 34% stake in Yunnan Jici Medical Technology [24] - Geer Software terminated its planned acquisition of a majority stake in Weipin Zhiyuan due to failure to reach agreement on key terms [25] Group 9 - Ningbo Fubang completed the absorption merger of its wholly-owned subsidiary, inheriting all assets and liabilities [26] - Zhongyuan Neipei signed a strategic cooperation framework agreement with Ningbo Puzhi Company for humanoid robot-related business [28] - Gongyuan Co. announced a business integration and relocation of its production lines in the East China region [29] Group 10 - Chlor-alkali Chemical's subsidiary plans to invest 2.975 billion yuan in a comprehensive utilization project for waste salt [30] - Kain Technology announced the departure of a core technical personnel, impacting its research capabilities [31] - ST Renfu received approval for clinical trials of a new drug for idiopathic pulmonary fibrosis [32] Group 11 - Sanbo Brain Science's established brain science fund has completed registration with the Asset Management Association of China [33] - Tongyou Technology plans to apply for a 70 million yuan credit line from Beijing Bank, using its property as collateral [34] - Bai Ao Intelligent signed a significant equipment sales contract worth approximately 27.5021 million yuan [35] Group 12 - ST Xinyan received all restructuring investment funds totaling 2.239 billion yuan, entering the execution phase of its restructuring plan [36] - Dalu Real Estate's subsidiary decided to terminate a planned acquisition of a 60% stake in Beijing Chengzhu Real Estate [38] - Huiyu Pharmaceutical's products received marketing approval in Italy and Norway [39]

每经AI快讯，同有科技（SZ 300302，收盘价：17.93元）12月19日晚间发布公告称，公司第五届第十五 次董事会会议于2025年12月19日在北京市海淀区地锦路9号院2号楼公司会议室以现场表决和通讯表决相 结合的形式召开。会议审议了《关于公司向银行申请授信额度的议案》等文件。 2025年1至6月份，同有科技的营业收入构成为：政府类客户占比89.18%，非政府客户占比10.82%。 截至发稿，同有科技市值为86亿元。 （记者 王晓波） 每经头条（nbdtoutiao）——海南封关首日直击：为中国探路，全球最大自贸港如何重塑开放边界？ ...

证券代码：300302 证券简称：同有科技 公告编号：2025-051 北京同有飞骥科技股份有限公司 第五届董事会第十五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、会议召开情况 公司申请授权董事长周泽湘先生全权代表公司签署上述授信额度内的有关 合同、协议、凭证等各项法律文件，办理相关抵押事宜。 具体内容详见公司同日于巨潮资讯网（www.cninfo.com.cn）披露的《关于公 司向银行申请授信额度的公告》。 北京同有飞骥科技股份有限公司（以下简称"公司"）第五届董事会第十五 次会议于 2025 年 12 月 19 日在北京市海淀区地锦路 9 号院 2 号楼公司会议室以 现场表决和通讯表决相结合的形式召开。本次会议的通知已于 2025 年 12 月 17 日以书面方式送达给所有董事。应出席本次会议的董事 8 人，实际出席本次会议 的董事 8 人。会议由董事长周泽湘先生主持，公司高级管理人员列席了会议。会 议的召集、召开符合《中华人民共和国公司法》及《公司章程》的规定。 二、会议审议情况 1、审议通过《关于公司向银行申请授信额度的议案》 ...

证券代码：300302 证券简称：同有科技 公告编号：2025-052 北京同有飞骥科技股份有限公司 关于公司向银行申请授信额度的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、交易概述 北京同有飞骥科技股份有限公司（以下简称"公司"）第五届董事会第十五 次会议审议通过《关于公司向银行申请授信额度的议案》，为满足公司日常经营 的资金需求，保证现金流量充足，公司拟向北京银行股份有限公司中关村分行（以 下简称"北京银行"）申请综合授信额度 7,000 万元，授信额度有效期限一年（具 体起始日期以银行审批为准），业务品种包括但不限于流动资金贷款、保函、银 行承兑汇票、商业承兑汇票贴现等。前述授信为北京银行对公司的续授信额度， 以上授信额度不等于公司的实际融资金额，实际融资金额应在授信额度内以银行 与公司实际发生的融资金额为准。 公司将以名下位于北京市海淀区地锦路 9 号院 2 号楼-1 至 4 层 101（不动产 证号为：X 京房权证海字第 373537 号）房产（以下简称"抵押房产"）为前述授 信提供抵押担保（以下简称"本次抵押"）。公司将按照法律法规要 ...

证券日报网讯12月17日晚间，同有科技（300302）发布公告称，截至本公告披露日，公司及控股子公司 提供的担保总额不超过41823.01万元(含50.00万美元，按照央行中间价折算)，占公司最近一期经审计净 资产的比例为39.28%；公司及控股子公司提供的担保总余额为32463.77万元，占公司最近一期经审计净 资产的比例为30.49%；公司及控股子公司对合并报表外单位提供的担保总余额为1000.00万元，占公司 最近一期经审计净资产的比例为0.94%。公司无逾期担保的情形，不涉及诉讼的担保金额情形及因担保 被判决败诉而应承担的损失金额等。 ...

Group 1 - CICC is planning to absorb and merge Dongxing Securities and Xinda Securities through a share swap, with trading resuming on December 18, 2025 [1] - Victory Energy's major shareholder plans to transfer 29.99% of its shares to Qiteng Robotics, with no plans for asset restructuring in the next 12 months [2] - China Metallurgical Group intends to repurchase A-shares worth 1 to 2 billion yuan at a price not exceeding 4.9 yuan per share [3] Group 2 - Boten Co. plans to acquire part of the Yifeng Yunding Fund for 1 yuan, with a commitment to fulfill a 20 million yuan capital contribution [4] - Tongyou Technology has initiated a 50 million yuan accounts receivable factoring business [5] - Gaode Infrared has received approval to issue debt financing tools totaling up to 3 billion yuan [6] Group 3 - Zhengyu Industrial's application for a private placement of A-shares has been approved by the Shanghai Stock Exchange [7] - China CRRC signed contracts totaling approximately 53.31 billion yuan, accounting for 21.6% of its projected 2024 revenue [9] - High Energy Environment's director increased his stake by purchasing 56,100 shares [10] Group 4 - Shantou Technology received approval from the CSRC for a convertible bond issuance [11] - Puyang Co. plans to use up to 900 million yuan of idle funds for entrusted wealth management [12] - Huibai New Materials has been awarded a government subsidy of 3.8 million yuan, with the first installment of 2.12 million yuan already received [13] Group 5 - Jiayuan Technology's shareholders plan to transfer 2.51% of the company's shares through a pricing inquiry [14] - Lingpai Technology's subsidiary terminated a 125 million yuan procurement contract due to market changes [15] - Juguang Technology intends to use up to 200 million yuan of idle funds for cash management [16] Group 6 - Zhongwen Media's subsidiary terminated a 200 million yuan private equity fund subscription due to market changes [17] - Zhifei Biological's modified vaccine for monkeypox has received clinical trial acceptance [19] - GeKowei's subsidiary received a government subsidy of 60 million yuan, accounting for 32.12% of the company's audited net profit [20] Group 7 - Wantai Biological's application for a clinical trial of a respiratory syncytial virus vaccine has been accepted [21] - Haitai Technology plans to increase capital in its Thai joint venture from 500,000 to 3 million Thai baht [22] - Shanghai Airport signed contracts for the transfer of duty-free store operating rights [23] Group 8 - Del Shares received approval to issue shares for the acquisition of 100% of Aizhuo Intelligent [24] - Novozymes' products have obtained EU CE IVDR certification [25] - Shibai Testing's chairman's assistant plans to increase shareholding by 8 to 12 million yuan [26] Group 9 - Huitian New Materials plans to invest approximately 97.68 million yuan in a lithium battery anode glue project [27] - Pudong Construction's subsidiaries won contracts totaling 1.649 billion yuan [29] - Acolyte's subsidiary has entered trial production for a special high-temperature resistant resin project [30] Group 10 - Pingzhi Information's subsidiary signed a 38.25 million yuan computing power service contract [31] - Tianma Technology is required to pay 5.3625 million yuan in taxes and penalties [32] - Yahon Pharmaceutical's clinical trial application for GLX002 has been approved [34]

证券代码：300302 证券简称：同有科技 公告编号：2025-050 北京同有飞骥科技股份有限公司 关于为全资子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、担保情况概述 北京同有飞骥科技股份有限公司（以下简称"公司"）于 2025 年 4 月 25 日 召开第五届董事会第十次会议和第五届监事会第八次会议，于 2025 年 5 月 20 日召开 2024 年年度股东大会，审议通过了《关于 2025 年度为全资子公司提供担 保额度预计的议案》。为满足全资子公司业务发展和经营需要，公司全资子公司 鸿秦（北京）科技有限公司（以下简称"鸿秦科技"）、湖南同有飞骥科技有限公 司（以下简称"湖南同有"）拟在未来 12 个月内分别向银行申请不超过 10,000 万元的综合授信额度，授信种类包括但不限于流动资金贷款、保函、信用证、银 行承兑汇票等。由公司为上述银行授信提供担保，预计合计担保额度不超过 20,000 万元，担保额度有效期自 2024 年年度股东大会审议通过之日起 12 个月。 具体内容详见公司于 2025 年 4 月 29 日在巨 ...